A Study to Evaluate the Analgesic Efficacy and Safety of VM902A in Subjects With Osteoarthritis (OA) of the Knee
Public ClinicalTrials.gov record NCT02847702. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a, Multicenter, Randomized, Double-blind, Placebo Controlled and Active-controlled, Parallel-group Study Evaluating the Analgesic Efficacy and Safety of VM902A in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the analgesic efficacy, safety, and tolerability of VM902A twice daily compared to placebo in subjects with moderate to severe chronic pain due to OA of the knee.
Study identification
- NCT ID
- NCT02847702
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 75 participants
Conditions and interventions
Conditions
Interventions
- VM902A 200-mg Capsules Drug
- VM902A 400-mg Capsules Drug
- Naproxen 500-mg Capsules Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2016 (Actual)
- Primary completion
- Nov 22, 2016 (Actual)
- Completion
- Nov 22, 2016 (Actual)
- Last update posted
- Nov 22, 2017
2016
United States locations
- U.S. sites
- 31
- U.S. states
- 12
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site | Birmingham | Alabama | 35216 | — |
| Investigational Site | Huntsville | Alabama | 35801 | — |
| Investigational Site | DeLand | Florida | 32720 | — |
| Investigational Site | Hialeah | Florida | 33012 | — |
| Investigational Site | Homestead | Florida | 33030 | — |
| Investigational Site | Jupiter | Florida | 33458 | — |
| Investigational Site | Orlando | Florida | 32806 | — |
| Investigational Site | Port Orange | Florida | 32129 | — |
| Investigational Site | Port Saint Lucie | Florida | 34952 | — |
| Investigational Site | The Villages | Florida | 32162 | — |
| Investigational Site | West Palm Beach | Florida | 33409 | — |
| Investigational Site | Columbus | Georgia | 31904 | — |
| Investigational Site | Avon | Indiana | 46123 | — |
| Investigational Site | Muncie | Indiana | 47304 | — |
| Investigational Site | Newton | Kansas | 67114 | — |
| Investigational Site | Prairie Village | Kansas | 66206 | — |
| Investigational Site | New Bedford | Massachusetts | 02740 | — |
| Investigational Site | Bay City | Michigan | 48706 | — |
| Investigational Site | Troy | Michigan | 48098 | — |
| Investigational Site | Kansas City | Missouri | 64114 | — |
| Investigational Site | St Louis | Missouri | 63141 | — |
| Investigational Site | Hartsdale | New York | 10530 | — |
| Investigational Site | Rosedale | New York | 11422 | — |
| Investigational Site | The Bronx | New York | 10467 | — |
| Investigational Site | Cincinnati | Ohio | 45219 | — |
| Investigational Site | Dayton | Ohio | 45417 | — |
| Investigational Site | Dublin | Ohio | 43016 | — |
| Investigational Site | Duncansville | Pennsylvania | 16635 | — |
| Investigational Site | Ogden | Utah | 84405 | — |
| Investigational Site | Salt Lake City | Utah | 84121 | — |
| Investigational Site | South Jordan | Utah | 84095 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02847702, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 22, 2017 · Synced Nov 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02847702 live on ClinicalTrials.gov.